한글목차

세계의 N-Formyl Peptide Receptor 2 시장 규모는 2022년 5,037만 달러에서 2030년에는 1억 4,071만 달러에 달할 것으로 예측되며, 2024-2030년 CAGR은 16.48%에 달할 것으로 보이고 있습니다.

북미의 N-Formyl Peptide Receptor 2 시장 규모는 2023년에 2,827만 달러, 유럽의 N-Formyl Peptide Receptor 2는 1,524만 달러에 달했습니다. 북미는 2023년에 56.12%인데 비해 유럽은 27.22%이며, 유럽의 비율은 2030년에는 26.50%에 달하며, 예측 기간 중 16.08%의 CAGR로 추이할 것으로 예측됩니다. 유럽의 N-Formyl Peptide Receptor 2 시장에 관해서는 독일이 2024-2030년에 15.84%의 CAGR로 확대하며, 2030년까지 841만 달러에 달할 것으로 예측되고 있습니다.

N-Formyl Peptide Receptor 2의 분류에는 아고니스트와 안타고니스트가 있습니다. 2023년, 아고니스트는 세계의 N-Formyl Peptide Receptor 2 시장에서 84.42%의 점유율을 차지했습니다. 또한 이 제품 부문은 2023년 4,252만 달러에서 2030년에는 1억 1,654만 달러에 달할 전망입니다.

N-Formyl Peptide Receptor 2는 주로 제약회사, 대학·연구기관, 기타 시장에서 사용되고 있습니다. N-Formyl Peptide Receptor 2 시장에서는 제약회사가 용도 면에서 중요한 점유율을 차지하고 있으며, 2024-2030년 16.79%의 CAGR로 확대하며, 2030년에는 1억 313만 달러에 달할 것으로 예상되고 있습니다.

세계의 N-Formyl Peptide Receptor 2 시장에 대해 조사했으며, 시장의 개요와 유형별, 용도별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.

목차

제1장 리포트의 개요

• 조사 범위
• 유형별 시장 분석
• 용도별 시장
• 전제와 제한
• 조사 목적
• 대상년

제2장 세계의 성장 동향

• 세계의 N-Formyl Peptide Receptor 2 시장 전망(2019-2030년)
• 세계의 N-Formyl Peptide Receptor 2의 성장 동향, 지역별
• N-Formyl Peptide Receptor 2 시장 역학

제3장 주요 참여 기업에 의한 경쟁 구도

제4장 N-Formyl Peptide Receptor 2 내역 데이터, 유형별

• 세계의 N-Formyl Peptide Receptor 2 시장 규모 실적(유형별)(2019-2024년)
• 세계의 N-Formyl Peptide Receptor 2의 예측 시장 규모(유형별)(2025-2030년)

제5장 N-Formyl Peptide Receptor 2 내역 데이터, 용도별

• 세계의 N-Formyl Peptide Receptor 2 시장 규모 실적(용도별)(2019-2024년)
• 세계의 N-Formyl Peptide Receptor 2 시장 규모 예측(용도별)(2025-2030년)

제6장 북미

제7장 유럽

제8장 아시아태평양

제9장 라틴아메리카

제10장 중동 및 아프리카

제11장 주요 기업의 개요

• Bio-Techne
• Abcam
• Enzo Life Sciences
• MedChemExpress
• Anaspec
• Merck
• Discoverx
• BioGems
• GenScript Company
• Alomone Labs

제12장 애널리스트의 시점/결론

제13장 부록

영문목차

The global N-Formyl Peptide Receptor 2 market size is projected to reach US$ 140.71 million by 2030, from US$ 50.37 million in 2022, at a CAGR of 16.48% during 2024-2030.

North America N-Formyl Peptide Receptor 2 market size is valued at US$ 28.27 million in 2023, while Europe N-Formyl Peptide Receptor 2 is 15.24 million. The proportion of the North America is 56.12% in 2023, while Europe is 27.22%, and it is predicted that Europe proportion will reach 26.50% in 2030, trailing a CAGR of 16.08% through the analysis period. As for the Europe N-Formyl Peptide Receptor 2 landscape, Germany is projected to reach US$ 8.41 million by 2030 trailing a CAGR of 15.84% during 2024-2030.

The classification of N-Formyl Peptide Receptor 2 includes Agonists and Antagonists. In 2023, Agonists accounted for a share of 84.42% in the global N-Formyl Peptide Receptor 2 market. In addition, this product segment is poised to reach US$ 116.54 million by 2030 from US$ 42.52 million in 2023.

N-Formyl Peptide Receptor 2 are mainly used in Pharmaceutical Company, Universities and Research Institutes and Others markets. In N-Formyl Peptide Receptor 2 market, Pharmaceutical Company holds an important share in terms of Application, and it is expected to reach US$ 103.13 million by 2030, at a CAGR of 16.79% during 2024 and 2030.

The N-Formyl Peptide Receptor 2 market competition will be still intense. Bio-Techne, Alomone Labs, Merck, Abcam and MedChemExpress is the leading manufacturer in global N-Formyl Peptide Receptor 2 market. The top 5 listed companies accounted for 45.27% of the market share in 2023 in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for N-Formyl Peptide Receptor 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding N-Formyl Peptide Receptor 2.

The N-Formyl Peptide Receptor 2 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global N-Formyl Peptide Receptor 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the N-Formyl Peptide Receptor 2 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

• Bio-Techne
• Abcam
• Enzo Life Sciences
• MedChemExpress
• Anaspec
• Merck
• Discoverx
• BioGems
• GenScript Company
• Alomone Labs

Segment by Type

• Agonists
• Antagonists

Segment by Application

• Pharmaceutical Company
• Universities and Research Institutes
• Others

By Region

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Europe
• Germany
• France
• U.K.
• Italy
• Switzerland
• Rest of Europe
• South America
• Brazil
• Argentina
• Rest of Latin America
• Middle East & Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of N-Formyl Peptide Receptor 2 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global N-Formyl Peptide Receptor 2 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Agonists
  • 1.2.3 Antagonists
• 1.3 Market by Application
  • 1.3.1 Global N-Formyl Peptide Receptor 2 Market Growth by Application: 2019 VS 2023 VS 2030
  • 1.3.2 Pharmaceutical Company
  • 1.3.3 Universities and Research Institutes
  • 1.3.4 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global N-Formyl Peptide Receptor 2 Market Perspective (2019-2030)
• 2.2 Global N-Formyl Peptide Receptor 2 Growth Trends by Region
  • 2.2.1 Global N-Formyl Peptide Receptor 2 Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 N-Formyl Peptide Receptor 2 Historic Market Size by Region (2019-2024)
  • 2.2.3 N-Formyl Peptide Receptor 2 Forecasted Market Size by Region (2025-2030)
• 2.3 N-Formyl Peptide Receptor 2 Market Dynamics
  • 2.3.1 N-Formyl Peptide Receptor 2 Industry Trends
  • 2.3.2 N-Formyl Peptide Receptor 2 Market Drivers
  • 2.3.3 N-Formyl Peptide Receptor 2 Market Challenges
  • 2.3.4 N-Formyl Peptide Receptor 2 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top N-Formyl Peptide Receptor 2 Players by Revenue
  • 3.1.1 Global Top N-Formyl Peptide Receptor 2 Players by Revenue (2019-2024)
  • 3.1.2 Global N-Formyl Peptide Receptor 2 Revenue Market Share by Players (2019-2024)
• 3.2 Global N-Formyl Peptide Receptor 2 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players Ranking by N-Formyl Peptide Receptor 2 Revenue
• 3.4 Global N-Formyl Peptide Receptor 2 Market Concentration Ratio
  • 3.4.1 Global N-Formyl Peptide Receptor 2 Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 6 and Top 3 Companies by N-Formyl Peptide Receptor 2 Revenue in 2023
• 3.5 Global Key Players of N-Formyl Peptide Receptor 2 Head office and Area Served
• 3.6 Global Key Players of N-Formyl Peptide Receptor 2 Product
• 3.7 Global Key Players of N-Formyl Peptide Receptor 2, Founded Date
• 3.8 Mergers & Acquisitions, Expansion Plans

4 N-Formyl Peptide Receptor 2 Breakdown Data by Type

• 4.1 Global N-Formyl Peptide Receptor 2 Historic Market Size by Type (2019-2024)
• 4.2 Global N-Formyl Peptide Receptor 2 Forecasted Market Size by Type (2025-2030)

5 N-Formyl Peptide Receptor 2 Breakdown Data by Application

• 5.1 Global N-Formyl Peptide Receptor 2 Historic Market Size by Application (2019-2024)
• 5.2 Global N-Formyl Peptide Receptor 2 Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America N-Formyl Peptide Receptor 2 Market Size (2019-2030)
• 6.2 North America N-Formyl Peptide Receptor 2 Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 6.3 North America N-Formyl Peptide Receptor 2 Market Size by Country (2019-2024)
• 6.4 North America N-Formyl Peptide Receptor 2 Market Size by Country (2025-2030)
• 6.5 United States
• 6.6 Canada
• 6.7 Mexico

7 Europe

• 7.1 Europe N-Formyl Peptide Receptor 2 Market Size (2019-2030)
• 7.2 Europe N-Formyl Peptide Receptor 2 Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 7.3 Europe N-Formyl Peptide Receptor 2 Market Size by Country (2019-2024)
• 7.4 Europe N-Formyl Peptide Receptor 2 Market Size by Country (2025-2030)
• 7.5 Germany
• 7.6 France
• 7.7 U.K.
• 7.8 Italy
• 7.9 Switzerland

8 Asia-Pacific

• 8.1 Asia-Pacific N-Formyl Peptide Receptor 2 Market Size (2019-2030)
• 8.2 Asia-Pacific N-Formyl Peptide Receptor 2 Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 8.3 Asia-Pacific N-Formyl Peptide Receptor 2 Market Size by Region (2019-2024)
• 8.4 Asia-Pacific N-Formyl Peptide Receptor 2 Market Size by Region (2025-2030)
• 8.5 China
• 8.6 Japan
• 8.7 South Korea
• 8.8 Southeast Asia
• 8.9 India
• 8.10 Australia

9 Latin America

• 9.1 Latin America N-Formyl Peptide Receptor 2 Market Size (2019-2030)
• 9.2 Latin America N-Formyl Peptide Receptor 2 Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 9.3 Latin America N-Formyl Peptide Receptor 2 Market Size by Country (2019-2024)
• 9.4 Latin America N-Formyl Peptide Receptor 2 Market Size by Country (2025-2030)
• 9.5 Argentina
• 9.6 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa N-Formyl Peptide Receptor 2 Market Size (2019-2030)
• 10.2 Middle East & Africa N-Formyl Peptide Receptor 2 Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 10.3 Middle East & Africa N-Formyl Peptide Receptor 2 Market Size by Country (2019-2024)
• 10.4 Middle East & Africa N-Formyl Peptide Receptor 2 Market Size by Country (2025-2030)
• 10.5 Middle East

11 Key Players Profiles

• 11.1 Bio-Techne
  • 11.1.1 Bio-Techne Company Details
  • 11.1.2 Bio-Techne Business Overview
  • 11.1.3 Bio-Techne N-Formyl Peptide Receptor 2 Introduction
  • 11.1.4 Bio-Techne Revenue in N-Formyl Peptide Receptor 2 Business (2019-2024)
• 11.2 Abcam
  • 11.2.1 Abcam Company Details
  • 11.2.2 Abcam Business Overview
  • 11.2.3 Abcam N-Formyl Peptide Receptor 2 Introduction
  • 11.2.4 Abcam Revenue in N-Formyl Peptide Receptor 2 Business (2019-2024)
  • 11.2.5 Abcam Recent Development
• 11.3 Enzo Life Sciences
  • 11.3.1 Enzo Life Sciences Company Details
  • 11.3.2 Enzo Life Sciences Business Overview
  • 11.3.3 Enzo Life Sciences N-Formyl Peptide Receptor 2 Introduction
  • 11.3.4 Enzo Life Sciences Revenue in N-Formyl Peptide Receptor 2 Business (2019-2024)
• 11.4 MedChemExpress
  • 11.4.1 MedChemExpress Company Details
  • 11.4.2 MedChemExpress Business Overview
  • 11.4.3 MedChemExpress N-Formyl Peptide Receptor 2 Introduction
  • 11.4.4 MedChemExpress Revenue in N-Formyl Peptide Receptor 2 Business (2019-2024)
• 11.5 Anaspec
  • 11.5.1 Anaspec Company Details
  • 11.5.2 Anaspec Business Overview
  • 11.5.3 Anaspec N-Formyl Peptide Receptor 2 Introduction
  • 11.5.4 Anaspec Revenue in N-Formyl Peptide Receptor 2 Business (2019-2024)
• 11.6 Merck
  • 11.6.1 Merck Company Details
  • 11.6.2 Merck Business Overview
  • 11.6.3 Merck N-Formyl Peptide Receptor 2 Introduction
  • 11.6.4 Merck Revenue in N-Formyl Peptide Receptor 2 Business (2019-2024)
• 11.7 Discoverx
  • 11.7.1 Discoverx Company Details
  • 11.7.2 Discoverx Business Overview
  • 11.7.3 Discoverx N-Formyl Peptide Receptor 2 Introduction
  • 11.7.4 Discoverx Revenue in N-Formyl Peptide Receptor 2 Business (2019-2024)
• 11.8 BioGems
  • 11.8.1 BioGems Company Details
  • 11.8.2 BioGems Business Overview
  • 11.8.3 BioGems N-Formyl Peptide Receptor 2 Introduction
  • 11.8.4 BioGems Revenue in N-Formyl Peptide Receptor 2 Business (2019-2024)
• 11.9 GenScript Company
  • 11.9.1 GenScript Company Company Details
  • 11.9.2 GenScript Company Business Overview
  • 11.9.3 GenScript Company N-Formyl Peptide Receptor 2 Introduction
  • 11.9.4 GenScript Company Revenue in N-Formyl Peptide Receptor 2 Business (2019-2024)
• 11.10 Alomone Labs
  • 11.10.1 Alomone Labs Company Details
  • 11.10.2 Alomone Labs Business Overview
  • 11.10.3 Alomone Labs N-Formyl Peptide Receptor 2 Introduction
  • 11.10.4 Alomone Labs Revenue in N-Formyl Peptide Receptor 2 Business (2019-2024)

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer